Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Opium is a medication used to treat moderate to severe pain. Opium is the first substance of the diverse group of the opiates.
- Mechanism
- Curator reviewed · 2 references
Opium produces its effects by activating specific G protein-coupled receptors in the brain, spinal cord, and peripheral nervous system. There are three major classes of opioid receptors being δ-opioid, κ-opioid and μ-opioid. Opium will generate an agonist activity which will later open the potassium channels and prevent the opening of voltage-gated calcium channels. This activity causes a reduction in neuronal excitability and inhibits the release of pain neurotransmitters.
The addictive character of opium is related to the binding to the μ-opioid receptors, which will activate dopaminergic neurons in the ventral tegmental area of the midbrain and thus, enhance the dopamine release in the nucleus accumbens. This mechanism involves the reward activity of the mesolimbic dopaminergic pathway.
- Primary indication
- Opium and its derivatives are the most commonly used medications for the treatment of acute and chronic pain.Curator reviewed · 1 structured indication
- First approval
- Canada, 2000
- Also known as
- Papaver somniferum exudate · Papaver somniferum resin
- Code names
- IDS-NO-001
Resolves to
What you can answer from here — as of September 29, 2026
Which drugs share a target with Opium, and which of those have an active Phase 3 trial?